Unable to load price data. Sorry.

¯\_(ツ)_/¯

Micrus Endovascular Corp (NASDAQ:MEND)

CAPS Rating: No stars

The Company develops, manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

How do you think NASDAQ:MEND will perform against the market?

Add Stock to CAPS Watchlist

All Players

40 Outperform
4 Underperform
 

All-Star Players

4 Outperform
0 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top NASDAQ:MEND Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:MEND VS S&P 500 (SPY)

Fools bullish on NASDAQ:MEND are also bullish on:

Fools bearish on NASDAQ:MEND are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about MEND.

Recs

0
Member Avatar PatBT (< 20) Submitted: 7/2/2010 5:24:54 PM : Outperform Start Price: $21.75 NASDAQ:MEND Score: -212.94

MEND's prospects are founded on innovative science and good management.

Recs

0
Member Avatar donsguesswork (48.50) Submitted: 12/3/2009 9:32:55 PM : Outperform Start Price: $14.16 NASDAQ:MEND Score: -131.85

MEND, AN EXCELLENT SYMBOL CHOICE FOR A COMPANY THAT DEVELOPS. MANUFACTURES AND MARKETS IMPLANTABLE AND DISPOSABLE DEVICES THAT TREAT CEREBAL VASCULAR DISEASES, THE ENTERPRISE EXTENDS ACROSS THE AMERICAN, EUROPE, AND ASIA. SECOND QTR NI OF $3.6 MIL COMPARED TO A $2.7 MIL LOSS 08, EPS .22, EST 0F .06. GROWTH WAS FUELED BY NEW PRODUCTS AND SELLING NEW ACCOUNTS. TOTAL CASH INCREASED TO$24.3 MIL.

Recs

0
Member Avatar brentan0 (< 20) Submitted: 10/22/2007 11:37:57 AM : Outperform Start Price: $19.07 NASDAQ:MEND Score: -109.96

This stock got hammered in mid September when they revised their revenue outlook. They were only reporting earnings delays however, and the overall earnings outlook is rosy.

Leaderboard

Find the members with the highest scoring picks in MEND.

Score Leader

pdieker

pdieker (< 20) Score: +202.09

The Score Leader is the player with the highest score across all their picks in MEND.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
pdieker < 20 7/22/2010 Underperform 3M $23.23 +0.60% +202.69% +202.09 0 Comment
msamet1 69.17 3/30/2007 1/8/2008 Underperform 3Y $24.20 -3.43% +146.50% +149.93 1 Comment
centxsooner < 20 4/5/2007 Underperform 5Y $24.10 -3.03% +143.62% +146.65 2 Comments
templex22 50.07 10/17/2007 Underperform 3W $19.27 +21.28% +126.09% +104.81 0 Comment
wileyjones < 20 4/28/2009 Outperform NS $6.50 +259.54% +288.40% -28.86 0 Comment
KidLucifer 89.61 4/14/2009 Outperform NS $7.04 +231.96% +294.58% -62.62 0 Comment
GeorgeG25 22.84 10/16/2006 Outperform NS $13.13 +77.99% +157.73% -79.74 0 Comment
Flipbsj 37.99 6/18/2008 Outperform NS $14.00 +66.93% +155.95% -89.03 0 Comment
WordTickers 31.06 2/25/2008 Outperform NS $14.21 +64.46% +155.32% -90.86 0 Comment
opies < 20 2/12/2008 Outperform NS $14.74 +58.55% +155.74% -97.20 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for MEND.